Saskia Bronder

Homburg, SL, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

Journal: European journal of immunology
Published: February 06, 2026

SARS-CoV-2-specific immunity after XBB.1.5 vaccination is not significantly altered by subsequent influenza vaccination in dialysis patients.

SARS-CoV-2-specific immunity after XBB.1.5 vaccination is not significantly altered by subsequent influenza vaccination in dialysis patients.

Journal: Scientific reports
Published: February 06, 2026

Immunogenicity and reactogenicity of the adjuvanted respiratory syncytial virus vaccine in patients with chronic kidney disease.

Immunogenicity and reactogenicity of the adjuvanted respiratory syncytial virus vaccine in patients with chronic kidney disease.

Journal: Clinical kidney journal
Published: December 02, 2025

The Role of Cytomegalovirus-specific Immunoglobulins as Modulators of Antigen-specific T-cell Expansion In Vitro.

The Role of Cytomegalovirus-specific Immunoglobulins as Modulators of Antigen-specific T-cell Expansion In Vitro.

Journal: Transplantation direct
Published: September 08, 2025

Cellular and humoral immunogenicity of respiratory syncytial virus vaccination in solid organ transplant recipients.

Cellular and humoral immunogenicity of respiratory syncytial virus vaccination in solid organ transplant recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 16, 2025

De Novo Immune Induction After COVID-19 Vaccination Under B-Cell Depletion Is Characterized by Robust T-Cellular Immunity in Patients With Inflammatory Central Nervous System Disease.

De Novo Immune Induction After COVID-19 Vaccination Under B-Cell Depletion Is Characterized by Robust T-Cellular Immunity in Patients With Inflammatory Central Nervous System Disease.

Journal: Brain and behavior
Published: February 26, 2025

CMV management of patients with leukopenia after CMV high-risk kidney transplantation.

CMV management of patients with leukopenia after CMV high-risk kidney transplantation.

Journal: Transplant immunology
Published: September 14, 2024

A promising boost for the Rift Valley fever vaccine pipeline.

A promising boost for the Rift Valley fever vaccine pipeline.

Journal: The Lancet. Infectious diseases
Published: June 30, 2024

Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients.

Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients.

Journal: NPJ vaccines
Published: September 04, 2023

SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals.

SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals.

Journal: Nature communications
Published: June 12, 2023

A novel Rift Valley fever vaccine.

A novel Rift Valley fever vaccine.

Journal: The Lancet. Infectious diseases
Published: February 16, 2023

Hemocompatibility tuning of an innovative glutaraldehyde-free preparation strategy using riboflavin/UV crosslinking and electron irradiation of bovine pericardium for cardiac substitutes.

Hemocompatibility tuning of an innovative glutaraldehyde-free preparation strategy using riboflavin/UV crosslinking and electron irradiation of bovine pericardium for cardiac substitutes.

Journal: Biomaterials advances
Published: September 26, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026